Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis by Timothy Vreeland, Diane Hale, Mark Faries, George E Peoples, Xianzhong Yu, Patrick McCarthy, Jessica Cindass, John Hyngstrom, James Jakub, Montaser F Shaheen, Guy Travis Clifton, Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, Anne E O’Shea, Robert Connor Chick, Franklin A Valdera, Ankur Tiwari, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Adam C Berger, Jeffrey J Sussman, Thomas E Wagner

Get full text

Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Result... by Spencer G. Van Decar, Elizabeth L. Carpenter, Alexandra M. Adams, Robert C. Chick, Guy T. Clifton, Alex Stojadinovic, Timothy J. Vreeland, Franklin A. Valdera, Ankur Tiwari, Anne E. O'Shea, Patrick M. McCarthy, Diane F. Hale, Phillip M Kemp Bohan, Annelies T. Hickerson, Jessica L. Cindass, John Hyngstrom, Adam C. Berger, James W. Jakub, Jeffrey J. Sussman, Montaser Shaheen, Xianzhong Yu, Thomas Wagner, Mark B. Faries, George E. Peoples

Get full text